Here we extend those results and show that we can induce human functional CD4+ and CD8+ Tregs that suppress xenogenic graft-versus-host disease (GvHD) in humanized mice using aAPC NPs, providing a proof-of-principle of immunotherapeutic restoration of immune homeostasis in conditions of immune dysregulation associated with chronic inflammation. The gene discussed is CD4; the disease is graft versus host disease.